Cargando…
Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
Immunotherapy has emerged as a viable approach in cancer therapy, with cytokines being of great interest. Interleukin IL-15 (IL-15), a cytokine that supports cytotoxic immune cells, has been successfully tested as an anti-cancer and anti-metastatic agent, but combinations with conventional chemother...
Autores principales: | Stravokefalou, Vasiliki, Stellas, Dimitris, Karaliota, Sevasti, Nagy, Bethany A., Valentin, Antonio, Bergamaschi, Cristina, Dimas, Konstantinos, Pavlakis, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880212/ https://www.ncbi.nlm.nih.gov/pubmed/36713398 http://dx.doi.org/10.3389/fimmu.2022.1014802 |
Ejemplares similares
-
Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021) -
Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
por: Bergamaschi, Cristina, et al.
Publicado: (2018) -
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10
por: Bergamaschi, Cristina, et al.
Publicado: (2020) -
Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes
por: Watson, Dionysios C., et al.
Publicado: (2018) -
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
por: Bergamaschi, Cristina, et al.
Publicado: (2021)